SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OpusX who wrote (1364)8/3/1999 12:55:00 PM
From: Angelo  Read Replies (1) of 1837
 
As much we all would like to see Cenestin take a good part of the
extrogen market, it is not going to happen over night.We need to
complete the trial initiated to have Cenestin used as a replacement for Premarin, and all that takes time.One think could stop the stock price going down is the approval for B.C..The short term is not very good, but that shouldn't be a matter. We all bought in for the long term and I would bet my house that 3 years from now DRMD would be over
$100 dollar stock on a 2 to 1 reverse split.I am disappointed for the short terme because i loaded shares on margin,and if it keeps on going down then I will have to sell some.Other then that i know we are in a good company.Now my advice to all the longs, if I was you and I had money buy some more and if comes down more buy more.This company
don't matter what happen to the market will still be alive.
Angelo
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext